GoodRx Holdings, Inc.
GDRX
$3.31
-$0.06-1.78%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 799.87M | 797.41M | 792.32M | 790.39M | 775.09M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 799.87M | 797.41M | 792.32M | 790.39M | 775.09M |
| Cost of Revenue | 50.59M | 49.11M | 48.22M | 46.69M | 53.73M |
| Gross Profit | 749.28M | 748.30M | 744.11M | 743.69M | 721.36M |
| SG&A Expenses | 435.52M | 443.31M | 451.62M | 462.29M | 473.74M |
| Depreciation & Amortization | 77.27M | 74.51M | 69.54M | 47.35M | 62.84M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 686.33M | 690.80M | 693.12M | 670.98M | 714.42M |
| Operating Income | 113.54M | 106.61M | 99.20M | 119.41M | 60.67M |
| Income Before Tax | 55.77M | 47.84M | 31.46M | -4.58M | -59.30M |
| Income Tax Expenses | 21.17M | 19.38M | 15.07M | 11.64M | -618.00K |
| Earnings from Continuing Operations | 34.60 | 28.45 | 16.39 | -16.22 | -58.68 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 34.60M | 28.45M | 16.39M | -16.22M | -58.68M |
| EBIT | 113.54M | 106.61M | 99.20M | 119.41M | 60.67M |
| EBITDA | 175.05M | 165.36M | 152.98M | 174.12M | 130.87M |
| EPS Basic | 0.09 | 0.08 | 0.04 | -0.04 | -0.14 |
| Normalized Basic EPS | 0.14 | 0.12 | 0.11 | 0.14 | 0.05 |
| EPS Diluted | 0.09 | 0.07 | 0.04 | -0.04 | -0.14 |
| Normalized Diluted EPS | 0.14 | 0.12 | 0.11 | 0.14 | 0.05 |
| Average Basic Shares Outstanding | 1.50B | 1.52B | 1.53B | 1.55B | 1.58B |
| Average Diluted Shares Outstanding | 1.51B | 1.54B | 1.55B | 1.57B | 1.59B |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |